1. Adams JB. Control of secretion and function
of C19-delta 5-steroids of the human adrenal
gland. Mol Cell Endocrinol 1985; 41:1–17.
2. Roberts E, Bologa L, Flood JF, Smith GE.
Effects of dehydroepiandrosterone and its
sulfate on brain tissue in culture and on
memory in mice. Brain Res. 1978; 406:357–
62.
3. Bologa L, Sharma J, Roberts E. 1987
Dehydroepiandrosterone, and its sulfated
derivative reduce neuronal death and enhance
astrocytic differentiation in brain cell cultures.
J Neurosci Res.1987; 17:225–34
4. Wolkowitz, Owen M., et al.
Dehydroepiandrosterone (DHEA) treatment of
depression. Biological Psychiatry.1997; 41(3):
311-18.
5. Debonnel G, Bergeron R, and de Montigny C.
Potentiation by dehydroepiandrosterone of the
neuronal response to N-methyl-D-aspartate in
the CA3 region of the rat dorsal hippocampus:
105
Rathna et al., Int J Med res Health Sci. 2013; 2(1):101-106
an effect mediated via sigma receptors.
Journal of Endocrinology 1996;150:S33-42.
6. Kimonides VG, Khatibi NH, Svendsen CN,
Sofroniew MV, Herbert J.
Dehydroepiandrosterone (DHEA) and DHEAsulfate
(DHEAS) protect hippocampal
neurons against excitatory amino acid-induced
neurotoxicity. Proceedings of the National
Academy of Sciences USA 1998; 95:1852-57.
7. Blauer KL, Poth M, Rogers WM, Bernton
EW. Dehydroepiandrosterone antagonises the
suppressive effects of dexamethasone on
lymphocyte proliferation. Endocrinology
1991; 129:3174-79.
8. Lupien SJ, de Leon M, de Santi S, Convit A,
Tarshish C, Nair NPV. Cortisol levels during
human aging predict hippocampal atrophy and
memory deficits. Nature Neuroscience 1998;
1(1):69-73.
9. Herbert J. Stress, the brain, and mental illness.
BMJ 1997; 315:530-35.
10. Hillen T, Lun A, Reischies FM, Borchelt M,
Steinhagen TE, Schaub RT. DHEA-S plasma
levels and incidence of Alzheimer's disease.
Biological Psychiatry 2000; 47(2):161-163.
11. Baulieu EE, Robel P. Dehydroepiandrosterone
and dehydroepiandrosterone Sulfate as
neuroactive neurosteroids. J Endocrinol 1996;
150:S221–39
12. Bergeron R, Montigny CD, Debonnel G.
Potentiation of neuronal NMDA response
induced by dehydroepiandrosterone and its
suppression by progesterone: effects mediated
by sigma receptors. J Neurosci 1996;
16(3):1193–202.
13. Wolf OT, Neumann O, Hellhammer DH,
Geiben AC, Strasburger CJ, Dressendorfer
RA, et al. Effects of a 2-week physiological
dehydroepiandrosterone substitution on
cognitive performance and well-being in
healthy elderly women and men. J Clin
Endocrinol Metab 1997; 82(7):2363–67.
14. Hillen, Thomas, et al. DHEA-S plasma levels
and incidence of Alzheimer’s disease.
Biological psychiatry.2000; 47(2): 161-63.
15. Davis SR, Shah S, McKenzie D, Kulkarni J,
Davison S, Bell R. Dehydroepiandrosterone
Sulfate Levels Are Associated with More
Favorable Cognitive Function in Women.
Clinical Endocrinology and Metabolism 2008;
93(3):801–08.
16. Mioshi, Eneida, et al. The Addenbrooke's
Cognitive Examination Revised (ACE‐R): a
brief cognitive test battery for dementia
screening. International journal of geriatric
psychiatry. 2006; 21(11): 1078-85.
Thank you for copying data from http://www.arastirmax.com